Greenwich LifeSciences logo

Greenwich LifeSciences

GLSI | NASDAQ
Chart Builder DCF Calculator
$13.76
-$1.18 (-7.90%)
At close: Nov 16, 2026, 4:00 PM ET
$13.95
+$0.19 (+1.38%)
After-hours: Nov 16, 2026, 7:30 PM ET
-7.90%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
24.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #942/1021 (Top 92%)

Key Statistics

Market Data

Market Cap $201.97M
1D Range
13.52 14.81
52W Range
7.85 33.57

Valuation (TTM)

PE -8.94
PB 64.80
EV/EBITDA -8.91

Valuation (NTM)

Forward PE N/A
Forward PEG -0.74
Price Target $50.00
Loading financial charts...

Profile

Greenwich LifeSciences, Inc. functions as a clinical-stage biopharmaceutical company, dedicated to developing innovative cancer immunotherapies. These treatments are primarily focused on breast cancer...

Sector Healthcare
Industry Biotechnology
Employees 13
IPO Date Sep 25, 2020
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$50.00
Upside
+263.37%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.